AbbVie’s Elahere has been approved in the European Union as a treatment for adults with advanced, platinum-resistant ovarian cancer.| Rare Cancer News
Phase 3 trial in nearly 500 advanced disease patients found combination therapy using Blenrep more effective at extending life than Darzalex.| Rare Cancer News
Steve Bryson is a science writer for Myeloma Research News with a PhD in biochemistry. He covers the latest news and information on a variety of myeloma topics.| Rare Cancer News
Based on a clinical trial, the CAR T-cell therapy was approved for relapsed or refractory precursor B-cell acute lymphoblastic leukemia.| Rare Cancer News
The FDA granted regenerative medicine advanced therapy status to the CAR T-cell therapy P-BCMA-ALLO1 for hard-to-treat multiple myeloma.| Rare Cancer News